186 related articles for article (PubMed ID: 582089)
1. Alkaline phosphatase isoenzyme patterns in hyperthyroidism.
Cooper DS; Kaplan MM; Ridgway EC; Maloof F; Daniels GH
Ann Intern Med; 1979 Feb; 90(2):164-8. PubMed ID: 582089
[TBL] [Abstract][Full Text] [Related]
2. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
Broulik PD; Stĕpán JJ; Límanová Z; Pacovský V
Endocrinol Exp; 1985 Sep; 19(3):165-9. PubMed ID: 3876205
[TBL] [Abstract][Full Text] [Related]
3. Alkaline phosphatase bone isoenzyme and osteocalcin in the serum of hyperthyroid cats.
Archer FJ; Taylor SM
Can Vet J; 1996 Dec; 37(12):735-9. PubMed ID: 9111692
[TBL] [Abstract][Full Text] [Related]
4. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
[TBL] [Abstract][Full Text] [Related]
5. [Alkaline phosphatase isoenzymes and hyperthyroidism].
Hampel R; Weber S; Rose HJ; Meng W; Nilius R
Z Gesamte Inn Med; 1981 Dec; 36(23):909-13. PubMed ID: 7342516
[TBL] [Abstract][Full Text] [Related]
6. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
Larsen PR
J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
[TBL] [Abstract][Full Text] [Related]
7. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
8. Disturbed mineral metabolism in hyperthyroidism: good correlation with tri-iodothyronine.
Manicourt D; Demeester-Mirkine N; Brauman H; Corvilain J
Clin Endocrinol (Oxf); 1979 Apr; 10(4):407-12. PubMed ID: 476975
[TBL] [Abstract][Full Text] [Related]
9. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
Garrel DR; Delmas PD; Malaval L; Tourniaire J
J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
[TBL] [Abstract][Full Text] [Related]
10. [On thyroid phosphatase in human serum (author's transl)].
van Husen N; Latzel H; Gerlach U
Klin Wochenschr; 1976 Apr; 54(8):393-4. PubMed ID: 1271694
[TBL] [Abstract][Full Text] [Related]
11. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
Laurberg P
J Clin Endocrinol Metab; 1987 May; 64(5):969-74. PubMed ID: 3558731
[TBL] [Abstract][Full Text] [Related]
12. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism.
Simsek G; Karter Y; Aydin S; Uzun H
Chin J Physiol; 2003 Dec; 46(4):181-6. PubMed ID: 15074839
[TBL] [Abstract][Full Text] [Related]
13. gamma-Glutamyl transpeptidase levels in thyroid disease.
Azizi F
Arch Intern Med; 1982 Jan; 142(1):79-81. PubMed ID: 6119059
[TBL] [Abstract][Full Text] [Related]
14. Tissue sources of serum alkaline phosphatase in 34 hyperthyroid cats: a qualitative and quantitative study.
Foster DJ; Thoday KL
Res Vet Sci; 2000 Feb; 68(1):89-94. PubMed ID: 10684764
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like cells (MC3T3-E1): a possible mechanism of hyperalkaline phosphatasia in hyperthyroidism.
Kasono K; Sato K; Han DC; Fujii Y; Tsushima T; Shizume K
Bone Miner; 1988 Sep; 4(4):355-63. PubMed ID: 3191290
[TBL] [Abstract][Full Text] [Related]
16. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
17. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
Takamatsu J; Kuma K; Mozai T
J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
[TBL] [Abstract][Full Text] [Related]
18. Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
Sobrinho LG; Limbert ES; Santos MA
J Clin Endocrinol Metab; 1977 Jul; 45(1):25-9. PubMed ID: 577497
[TBL] [Abstract][Full Text] [Related]
19. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
Koukkou E; Panayiotidis P; Alevizou-Terzaki V; Thalassinos N
J Clin Endocrinol Metab; 1991 Oct; 73(4):771-6. PubMed ID: 1909702
[TBL] [Abstract][Full Text] [Related]
20. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
